MiniMed Group, Inc. (MMED) Cash Flow Statement
MiniMed Group, Inc. (MMED) generated -$105.0M of operating cash flow over the twelve months to 2026-07-31, spent $211.0M on capital expenditure and had free cash flow of -$316.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
MMEDMiniMed Group, Inc.Follow MMED — free
—
Price chart with a free account
- Market cap
- 5.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2024 Apr 24 | FY2025 Apr 25 | FY2026 Apr 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | 0.04 | 0.14 | -0.20 | -0.11 | |
| Capital expenditure | 0.15 | 0.19 | 0.22 | -0.21 | |
| Free cash flow | -0.11 | -0.05 | -0.42 | -0.32 | |
| Stock-based compensation | 0.04 | 0.04 | 0.05 | — |
USD billions · SEC XBRL
MiniMed Group, Inc. — questions
- What is MiniMed Group, Inc.'s operating cash flow?
- -$105.0M over the twelve months to 2026-07-31.
- How much does MiniMed Group, Inc. spend on capital expenditure?
- $211.0M over the twelve months to 2026-07-31.
- What is MiniMed Group, Inc.'s free cash flow?
- -$316.0M over the twelve months to 2026-07-31: operating cash flow minus capital expenditure.
Every figure on this page comes from MiniMed Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.